Milk derived bioactive peptides and their impact on human health – A review

Saudi Journal of Biological Sciences

Volumn 23, Issue 5, 2016, Pages 577-583

  Mohanty, D P ^a   Mohapatra, S ^a   Misra, S ^b   Sahu, P S ^b  

^a ORISSA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (India)

^b INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

Bioactive peptides; Healthcare; Milk; Production; Purification

Indexed keywords

EID: 84933574298     PISSN: 1319562X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sjbs.2015.06.005     Document Type: Review

References (61)

1. Abuja, P., Albertini, R., Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin. Chim. Acta 306 (2001), 1–17.
2. Bellamy, W.R., Wakabayashi, H., Takase, M., Kawase, K., Shimamura, S., Tomita, M., Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med. Microbiol. Immunol. 182 (1993), 97–105.
3. Bracquart, P., Lorient, D., Etude des acides aminés sur la croissance de Streptococcus thermophilus. Milchwissenschaft 32 (1979), 221–224.
4. Brantl, V., Novel opioid peptides derived from human beta-casein: human beta-casomorphins. Eur. J. Pharmacol. 106 (1984), 213–1214.
5. Bruck, W.M., Graverholt, G., Gibson, G.R., A two-stage continuous culture system to study the effect of supplemental α-lactalbumin and glycomacropeptide on mixed cultures of human gut bacteria challenged with enteropathogenic Escherichia coli and Salmonella serotype typhimurium. J. Appl. Microbiol. 95 (2003), 44–53.
6. Calvo, C.F., Cesselin, F., Gelman, M., Glowinski, J., Identification of an opioid peptide secreted by rat embryonic mixed brain cells as a promoter of macrophage migration. Eur. J. Neurosci. 12 (2000), 2676–2684.
7. Cervato, G., Cazzola, R., Cestaro, B., Studies on the antioxidant activity of milk caseins. Int. J. Food Sci. Nutr. 50 (1999), 291–294.
8. Christensen, J.E., Dudley, E.G., Pederson, J.A., Steele, J.L., Peptidases and amino acid catabolism in lactic acid bacteria. Antonie Van Leeuwenhoek 76 (1999), 217–246.
9. Clare, D.A., Catignani, G.L., Swaisgood, H.E., Biodefense properties of milk: the role of antimicrobial proteins and peptides. Curr. Pharm. Des. 9 (2003), 1239–1255.
10. Daniel, H., Vohwinkel, M., Rehner, G., Effect of casein and beta-casomorphins on gastrointestinal motility in rats. J. Nutr. 3 (1990), 252–257.
11. Dziuba, J., Minkiewicz, P., Nalecz, D., Iwaniak, A., Database of biologically active peptide sequences. Nahrung 43 (1999), 190–195.
12. Farnadu, S., Evans, R.W., Lactoferrin – a multifunctional protein with antimicrobial properties. Mol. Immunol. 40 (2003), 395–405.
13. Farrell, H.M., Jimenez-Flores, R., Bleck, G.T., Brown, E.M., Butler, J.E., Creamer, L.K., Hicks, C.L., Hollar, C.M., Ng-Kwai-Hang, K.F., Swaisgood, H.E., Nomenclature of the proteins of cows’ milk–sixth revision. J. Dairy Sci. 87 (2004), 1641–1674.
14. FitzGerald, R.J., Meisel, H., Milk protein hydrolysates and bioactive peptides. Adv. Dairy Chem. 3 (2003), 675–698.
15. FitzGerald, R.J., Murray, B.A., Walsh, D.J., Hypotensive peptides from milk proteins. J. Nutr. 134 (2004), 980–988.
16. Gauthier, S.F., Pouliot, Y., Maubois, J.L., Growth factors from bovine milk and colostrum: composition, extraction and biological activities. Lait 86 (2006), 99–125.
17. Gill, H.S., Doull, F., Rutherfurd, K.J., Cross, M.L., Immunoregulatory peptides in bovine milk. Brit. J. Nutr. 84 (2000), 111–117.
18. Gobbetti, M., Stepaniak, L., De Angelis, M., Corsetti, A., DiCagno, R., Latent bioactive peptides in milk proteins: proteolytic activation and significance in dairy processing. Crit. Rev. Food Sci. Nutr. 42 (2002), 223–239.
19. Gobbetti, M., Minervini, F., Rizzello, C.G., Angiotensin I converting-enzyme-inhibitory and antimicrobial bioactive peptides. Int. J. Dairy Technol. 57 (2004), 172–188.
20. Hadden, J.W., Immunotherapy of human immunodeficiency virus infection. Trends Pharmacol. Sci. 12 (1991), 107–111.
21. Halliwell, B., Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward?. Cardiovasc. Res. 47 (2000), 410–418.
22. Halliwell, B., Whiteman, M., Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br. J. Pharmacol. 142 (2004), 231–255.
23. Jauhiainen, T., Korpela, R., Milk peptides and blood pressure. J. Nutr. 137 (2007), 825–829.
24. Kitts, D.D., Weiler, K., Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Curr. Pharm. Des. 9 (2003), 1309–1323.
25. Korhonen, H., Pihlanto, A., Food-derived bioactive peptides opportunities for designing future foods. Curr. Pharm. Des. 9 (2003), 1297–1308.
26. Korhonen, H., Pihlanto, A., Technological options for the production of health-promoting proteins and peptides derived from milk and colostrum. Curr. Pharm. Design 13 (2007), 829–8434.
27. Lahov, E., Regelson, W., Antibacterial and immunostimulating casein-derived substances from milk: caseicidin, isracidin peptides. Food Chem. Toxicol. 34 (1996), 131–145.
28. Lindmark-Mansson, H., Kesson, B., Antioxidative factors in milk. Br. J. Nutr. 84 (2000), 103–110.
29. Manso, M.A., López-Fandiño, R., κ-casein macropeptides from cheese whey physicochemical, biological, nutritional, and technological features for possible use. Food Res. Int. 20 (2004), 329–355.
30. Maruyama, S., Suzuki, H., A peptide inhibitor of angiotensin I-converting enzyme in the tryptic hydrolysate of casein. Agric. Biol. Chem. 46 (1982), 1393–1394.
31. Maruyama, S., Nakagomi, K., Tomizuka, N., Suzuki, H., Angiotensin I-converting enzyme inhibitor derived from an enzymatic hydrolysate of casein. II. Isolation and bradykinin-potentiating activity on the uterus and the ileum of rats. Agric. Biol. Chem. 49 (1985), 1405–1409.
32. Maruyama, S., Mitachi, H., Awaya, J., Kurono, M., Tonizuka, N., Suzuki, H., Angiotensin I-converting enzyme inhibitory activity of the C-terminal hexapeptide of αs1-casein. Agric. Biol. Chem. 51 (1987), 2557–2561.
33. Matthies, H., Stark, H., Hartrodt, B., Ruethrich, H.L., Spieler, H.T., Barth, A., Neubert, K., Derivatives of beta-casomorphins with high analgesic potency. Peptides 5 (1984), 463–470.
34. McDonagh, D., FitzGerald, R.J., Production of caseinophosphopeptides (CPPs) from sodium caseinate using a range of commercial protease preparations. Int. Dairy J. 8 (1998), 39–45.
35. Meisel, H., Overview on milk protein-derived peptides. Int. Dairy J. 8 (1998), 363–373.
36. Meisel, H., Bockelmann, W., Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties. Antonie Van Leeuwenhoek 76 (1999), 207–215.
37. Meisel, H., FitzGerald, R.J., Opioid peptides encrypted in milk protein sequences. Brit. J. Nutr. 84 (2000), 27–31.
38. Meisel, H., FitzGerald, R.J., Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects. Curr. Pharm. Des. 9 (2003), 1289–1295.
39. Meisel, H., Schlimme, E., Milk proteins: precursors of bioactive peptides. Trends Food Sci. Technol. 1 (1990), 41–43.
40. Migliore-Samour, D., Jollès, P., Casein Prohormone with an immunomodulating role for the newborn. Experientia 44 (1988), 188–193.
41. Mohanty, D.P., Tripathy, P., Mohapatra, S., Samantaray, D.P., Bioactive potential assessment of antibacterial peptide produced by Lactobacillus isolated from milk and milk products. Int. J. Curr. Microbiol. Appl. Sci. 3 (2014), 72–80.
42. Molina, P.E., Abumrad, N.N., Metabolic effects of opiates and opioid peptides. Adv. Neuroimmunol. 4 (1994), 105–116.
43. Monnai, M., Horimoto, Y., Otani, H., Immunomodificatory effect of dietary bovine κ-caseinoglycopeptide on serum antibody levels and proliferative responses of lymphocytes in mice. Milchwissenschaft 53 (1998), 129–132.
44. Okada, Y., Okada, M., Scavenging effect of water soluble proteins in broad beans on free radicals and active oxygen species. J. Agric. Food Chem. 46 (1998), 401–406.
45. Pan, Y., Rowney, M., Guo, P., Hobman, P., Biological properties of lactoferrin: an overview. Aust. J. Dairy Technol. 62 (2007), 31–42.
46. Perpetuo, E.A., Juliano, L., Lebrun, I., Biochemical and pharmacological aspects of two bradykinin-potentiating peptides obtained from tryptic hydrolysis of casein. J. Protein Chem. 22 (2003), 601–606.
47. Pihlanto-Leppala, A., Antila, P., Mantsala, P., Hellman, J., Opioid peptides produced by in vitro proteolysis of bovine caseins. Int. Dairy J. 41 (1994), 291–301.
48. Pihlanto-Leppala, A., Koskinen, P., Paakkari, I., Tupasela, T., Korhonen, H., Opioid whey protein peptides obtained by membrane filtration. IDF Bull. 311 (1996), 36–38.
49. Recio, I., Visser, S., Two ion-exchange methods for the isolation of antibacterial peptides from lactoferrin in situ enzymatic hydrolysis on an ion-exchange membrane. J. Chromatogr. 831 (1999), 191–201.
50. Rival, S.G., Boeriu, C.G., Wichers, H.J., Caseins and casein hydrolysates. 2. Antioxidative properties Peroral calcium dosage of infants. Acta Med. Scand. 55 (2001), 247–255.
51. Saito, T., Nakamura, T., Kitazawa, H., Kawai, Y., Itoh, T., Isolation and structural analysis of antihypertensive peptides that exist naturally in gouda cheese. J. Dairy Sci. 83 (2000), 1434–1440.
52. Schlimme, E., Meisel, H., Bioactive peptides derived from milk proteins. Structural, physiological and analytical aspects. Nahrung 39 (1995), 1–20.
53. Sturner, R.A., Chang, K.J., Opioid peptide content in infant formulas. Pediatr. Res. 23 (1988), 4–10.
54. Suetsuna, K., Ukeda, H., Ochi, H., Isolation and characterization of free radical scavenging activities peptides derived from casein. J. Nutr. Biochem. 11 (2000), 128–131.
55. Tome, D., Debabbi, H., Physiological effects of milk protein components. Int. Dairy J. 8 (1998), 383–392.
56. Van der Kraan, M.I., Nazmi, K., Teeken, A., Groenink, J., vant Hof, W., Veerman, E.C., Bolscher, J.G., Nieuw Amerongen, A.V., Lactoferrampin, an antimicrobial peptide of bovine lactoferrin, exerts its candidacidal activity by a cluster of positively charged residues at the C-terminus in combination with a helix-facilitating N-terminal part. Biol. Chem. 386 (2004), 137–142.
57. Vermeirssen, V., Van, C.J., Verstraete, W., Bioavailability of angiotensin I converting enzyme inhibitory peptides. Br. J. Nutr. 92 (2004), 357–366.
58. Wong, P.Y.Y., Kitts, D.D., Chemistry of butter milk solid antioxidant activity. J. Dairy Sci. 86 (2003), 1541–1547.
59. Xu, R.J., Bioactive peptides in milk and their biological and health implications. Food Rev. Int. 14 (1998), 1–16.
60. Yamamoto, N., Ejiri, M., Mizuno, S., Biogenic peptides and their potential use. Curr. Pharm. Des. 9 (2003), 1345–1355.
61. Zucht, H.D., Raida, M., Adermann, K., Magert, H.J., Forssman, W.G., Casocidin-I: a casein αs2-derived peptide exhibits antibacterial activity. FEBS Lett. 372 (1995), 185–188.